1. Home
  2. CRSP vs SWX Comparison

CRSP vs SWX Comparison

Compare CRSP & SWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$50.20

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Logo Southwest Gas Holdings Inc. (DE)

SWX

Southwest Gas Holdings Inc. (DE)

HOLD

Current Price

$88.56

Market Cap

5.9B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
SWX
Founded
2013
1931
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.9B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
CRSP
SWX
Price
$50.20
$88.56
Analyst Decision
Buy
Strong Buy
Analyst Count
23
10
Target Price
$85.63
★ $99.78
AVG Volume (30 Days)
★ 1.5M
540.1K
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
★ 2.99%
EPS Growth
N/A
★ 120.29
EPS
N/A
★ 2.49
Revenue
$289,590,000.00
★ $5,433,972,000.00
Revenue This Year
$1,052.09
N/A
Revenue Next Year
$273.88
$6.24
P/E Ratio
★ N/A
$34.85
Revenue Growth
★ 9169.85
9.56
52 Week Low
$44.12
$76.99
52 Week High
$70.74
$94.47

Technical Indicators

Market Signals
Indicator
CRSP
SWX
Relative Strength Index (RSI) 41.49 57.27
Support Level $45.61 $83.99
Resistance Level $60.71 $89.83
Average True Range (ATR) 2.51 1.46
MACD -0.48 0.72
Stochastic Oscillator 8.96 84.31

Price Performance

Historical Comparison
CRSP
SWX

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About SWX Southwest Gas Holdings Inc. (DE)

Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution segment. The Natural gas distribution segment encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. Its division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers.

Share on Social Networks: